Rapamycin alleviates toxicity of different aggregate-prone proteins.
By Z. Berger, B. Ravikumar, Fiona M Menzies, L. Oroz, B. Underwood, M. Pangalos, I. Schmitt, U. Wullner, B. Evert, Cahir O'Kane and 1 more. Human Molecular Genetics, 2006
682 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Epidemiology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/40df178ba992e2e2e8bfa9dde7d3f50c022ccd14
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
- A. Cuervo
- Fiona M Menzies
- Sovan Sarkar
- S. Imarisio
- A. Cordenier
- Cahir O'Kane
- D. Rubinsztein
- Patrick R. Hof
In Epidemiology
- A. Cuervo
- D. Rubinsztein
- Fiona M Menzies
- Esther Wong
- Susmita Kaushik
- Sovan Sarkar
- S. Imarisio
- Angeleen Fleming
In Molecular Biology
- Fiona M Menzies
- A. Cuervo
- Stefan Schreiber
- S. Martens
- E. Mandelkow
- D. Rubinsztein
- Gabriele Zaffagnini
- I. Slaninová
Citations in the corpus
- Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies (2016, background): “, by rapamycin that induces macroautophagy [175], inhibitors of Hsp90 chaperone protein that binds to misfolded proteins or by immunotherapeutic approaches [176].”
- Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities. (2017, positive): “…microscopy - the reduction of the large aggregates after autophagy induction may reflect a reduced input of the smaller species into the aggregates and the flux of the mutant proteins on and off the aggregates (Berger et al., 2006; Ravikumar et al., 2002; Ravikumar et al., 2004; Webb et al., 2003).”
- Role of autophagy in cancer (2007, neutral): “, and aggregation-prone proteins and protein aggregate”
- Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. (2009, background): “Up to now, the degradation of Tau by the ubiquitin–proteasome system has been investigated by several authors (13,14,16,17,20), whereas the involvement of the autophagy–lysosome system has received less attention (23,31,38).”
- Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. (2007, methodology): “Although these SMIRs and SMERs were discovered as modulators of the effects of rapamycin on yeast growth, we tested if they were also modulators of mammalian autophagy.”
- Mechanisms of Selective Autophagy (2016, positive): “Rapamycin treatment promoted the clearance of aggregated proteins by autophagy in mammalian cell lines and Drosophila melanogaster [111].”